Trial Profile
Long-term efficacy of ranibizumab in patients with retinal angiomatous proliferation: A retrospective case series study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 08 Nov 2016 New trial record